These Cheap Biotech Stocks Signal Low-Beta Growth Potential
Two affordable biotech names are drawing attention for potential low-beta growth as AI-driven tools reshape pipelines...
This article compares index fund choices for retirement in 2024, focusing on S&P 500 vs Total Market performance and cost considerations.
24,938 articlesTwo affordable biotech names are drawing attention for potential low-beta growth as AI-driven tools reshape pipelines...
Jim Cramer cautions that AI stock surges can reverse sharply if earnings fail to accelerate, a warning that comes as ...
A pair of geopolitical developments is reviving appetite for riskier assets and triggering a chip-stock rally back fu...
A leading market strategist argues the AI-led pullback is routine profit-taking after a rapid rally, with the AI infr...
AI stocks are pausing in an unusual air pocket, with Meta and Microsoft trading like bear-market bets. Analysts warn ...
A cooler June CPI prints suggest inflation is cooling, potentially giving the Fed room to hold rates steady. Markets ...
The Supreme Court ruled that broad emergency tariffs under IEEPA were unlawful, a decision that curbs presidential po...
Geopolitical tensions push markets lower as inflation and energy risk linger. This piece analyzes Coca-Cola as a cand...
February CPI data matched expectations, keeping the Fed on track. The crypto market weighs how will bitcoin’s price r...
Analysts see SpaceX, OpenAI, and Anthropic pursuing record mega-IPOs in 2026, potentially reshaping liquidity for ven...
Celanese (CE) stands at an inflection point as 2026 begins. This article breaks down the potential drivers behind cel...
Warren Buffett’s Berkshire Hathaway more than triples its Alphabet stake to roughly $16.6 billion in the latest quart...